Literature DB >> 11824665

Developing a comprehensive mechanical support program.

D N Helman1, M C Oz.   

Abstract

As cardiac surgery centers appreciate that ventricular assist devices (VAD) can dramatically impact patient survival as a bridge to transplant or recovery, and possibly permanent therapy, increasing numbers will desire to establish mechanical support programs. A number of vital elements must be put in place in order to operate a successful mechanical support program. Of utmost importance is the assembly of a dedicated team focused on comprehensive care of critically ill patients in need of circulatory support. An ongoing commitment from anesthesiologists, cardiologists, nephrologists, and other support staff is essential. Selection of complementary assist devices should be made to cover the spectrum of required support scenarios, both short- and long-term. Outpatient therapy has become increasingly important in mechanical cardiac assistance and establishment of an office where "LVAD coordinators" see outpatients facilitates this aspect of the program. Critically ill patients in need of cardiac assistance may benefit from specialized medical therapies such as: (1) intravenous arginine vasopressin for vasodilatory hypotension; (2) inhaled nitric oxide for right heart failure; (3) aprotinin to reduce hemorrhage; and (4) early enteral feeding in an effort to reduce infectious complications and improve rehabilitation following VAD implantation. A regional network with spoke hospitals centered around a hub hospital with long-term VAD and heart transplant programs can improve survival of patients with postcardiotomy cardiogenic shock via early transfer to the hub hospital. In this article, we describe the components of our mechanical support program that have allowed us to successfully support patients with heart failure in need of circulatory support.

Entities:  

Mesh:

Year:  2001        PMID: 11824665     DOI: 10.1111/j.1540-8191.2001.tb00509.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  General and acute care surgical procedures in patients with left ventricular assist devices.

Authors:  George J Arnaoutakis; Gregory J Bittle; Jeremiah G Allen; Eric S Weiss; Jennifer Alejo; William A Baumgartner; Ashish S Shah; Christopher L Wolfgang; David T Efron; John V Conte
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

Review 2.  Mechanical bridge to decision: what are the options for the management of acute refractory cardiogenic shock?

Authors:  Daniel Goldstein; Siyamek Neragi-Miandoab
Journal:  Curr Heart Fail Rep       Date:  2011-03

3.  Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.

Authors:  Jeremiah G Allen; Eric S Weiss; Justin M Schaffer; Nishant D Patel; Susan L Ullrich; Stuart D Russell; Ashish S Shah; John V Conte
Journal:  J Heart Lung Transplant       Date:  2009-10-17       Impact factor: 10.247

Review 4.  Which cardiac surgical patients can benefit from placement of a pulmonary artery catheter?

Authors:  Marco Ranucci
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 5.  Perioperative pharmacotherapy in patients with left ventricular assist devices.

Authors:  Nicholas C Dang; Yoshifumi Naka
Journal:  Drugs Aging       Date:  2004       Impact factor: 4.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.